Open-House-Biologika-Rabattverträge 2025-26 - Insulin lispro
Original notice title
Germany – Pharmaceutical products – Open-House-Biologika-Rabattverträge 2025-26 - Insulin lispro (ATC: A10AB04, Wirkstärke: 100 U/ml)
Opportunity Score
Why this score?
Opportunity
50 / 100
Complexity
40 / 100
Risk factors
No estimated contract value or volume is provided, making it difficult to assess potential revenue.
The procedure is not a standard public procurement; it relies on specific SGB V and AMG provisions. The dispute resolut...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- Supplies contract
- 1 lot
- Duration until Oct 2027
- Pharmaceutical discount agreements for Insulin lispro (ATC: A10AB04, 100 U/ml)
- Open House procedure with uniform conditions, no negotiations
Show full summary
Open House procedure by Techniker Krankenkasse and other German health insurance companies to conclude discount agreements (Rabattverträge) for Insulin lispro (ATC: A10AB04, 100 U/ml) under § 130a Abs. 8 SGB V. The procedure is open to all qualified pharmaceutical entrepreneurs, with no exclusivity, and contracts can be concluded continuously until the end date. The contract term is 24 months from November 1, 2025, to October 31, 2027. No estimated value is provided.
Risks
No estimated contract value or volume is provided, making it difficult to assess potential revenue.
The procedure is not a standard public procurement; it relies on specific SGB V and AMG provisions. The dispute resolut...
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Must be a pharmaceutical entrepreneur (pharmazeutischer Unternehmer) as defined in § 4 Abs. 18 AMG
- Registered office in Germany, EU, or EEA (§ 9 Abs. 2 AMG)
- Valid marketing authorization for the product (§ 21 AMG) or equivalent right
Requirements may be incomplete.
Award Criteria
Lot 1
Buyer
Location
Hamburg, DEU
Website
Identifier
992-80116-93
Activity
Health
Lots (1)
LOT-0001
Open-House-Biologika-Rabattverträge 2025-26 - Insulin lispro
Conclusion of discount agreements for the active substance Insulin lispro (ATC: A10AB04, 100 U/ml) under an Open House procedure. No negotiations, uniform conditions, non-exclusive.
Location
Duration
Category
Award Criteria
Deadline
Award details
Ziel ist der Abschluss von Arzneimittelrabattverträgen nach § 130a Abs. 8 SGB V zu dem Wirkstoff Insulin lispro (ATC: A10AB04, Wirkstärke: 100 U/ml) im Rahmen eines Open-House-Verfahrens.
Value note
Show original TED data
Original lot title
Open-House-Biologika-Rabattverträge 2025-26 - Insulin lispro (ATC: A10AB04, Wirkstärke: 100 U/ml)
Original TED description
Ziel ist der Abschluss von Arzneimittelrabattverträgen nach § 130a Abs. 8 SGB V zu dem Wirkstoff Insulin lispro (ATC: A10AB04, Wirkstärke: 100 U/ml) im Rahmen eines Open-House-Verfahrens.
Procurement Details
- Publication date
- 09 Sep 2025
- Languages
- German
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 589353-2025
Documents (1)
Similar tenders
Germany – Site preparation work – VE111 Baustelleneinrichtung (119VM514 / Kronsh,SanDstBw,Ersatzneub. ZInstSanBw)
Poland – Advertising and marketing services – Zaplanowanie i realizacja kampanii Ministerstwa Finansów z zakresu działalności resortu finansów
France – Insurance services – Prestations de services d'assurance pour groupement le groupement hospitalier de territoire Yvelines Nord
Finland – Architectural, construction, engineering and inspection services – Tietomallikoordinaattori-, inventointimittaus- ja mallinnuspalvelujen puitejärjestely 2026-2028 (2028-2030)
Greece – Cultural event organisation services – ΛΕΙΤΟΥΡΓΙΑ ΤΟΥ ΘΕΑΤΡΟΥ ΟΛΥΜΠΙΑ ΜΑΡΙΑ ΚΑΛΛΑΣ ΜΕ ΕΞΕΙΔΙΚΕΥΜΕΝΟ ΠΡΟΣΩΠΙΚΟ
Spain – Architectural, construction, engineering and inspection services – Redacción del Proyecto Básico y de Ejecución, Redacción del Estudio de Seguridad y Salud y Dirección de Obra para la construcción del I.E.S. Nº 1 de 12+0 uds. (Fase 1) en la urbanización El Bosque de Pioz (Guadalajara).
Opportunity Score
Why this score?
Opportunity
50 / 100
Complexity
40 / 100
Risk factors
No estimated contract value or volume is provided, making it difficult to assess potential revenue.
The procedure is not a standard public procurement; it relies on specific SGB V and AMG provisions. The dispute resolut...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications